<SEC-DOCUMENT>0001140361-21-013009.txt : 20210416
<SEC-HEADER>0001140361-21-013009.hdr.sgml : 20210416
<ACCEPTANCE-DATETIME>20210416064819
ACCESSION NUMBER:		0001140361-21-013009
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210416
FILED AS OF DATE:		20210416
DATE AS OF CHANGE:		20210416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		21830078

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>nc10023226x1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.4.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: center; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"></div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">&#160;FORM 6-K</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND
      EXCHANGE COMMISSION</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Washington,
      D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Report of
      Foreign Private Issuer</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Pursuant to Rule
      13a-16 under</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">t<font style="font-weight: bold;">he
        Securities Exchange Act of 1934</font></div>
    <div><br>
    </div>
    <div style="text-align: center;">For the month ended April, 2021</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">ICON plc</div>
    <div style="text-align: center;">(Registrant&#8217;s name)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">333-08704</div>
    <div style="text-align: center;">&#160;(Commission file number)</div>
    <div><br>
    </div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland</div>
    <div style="text-align: center;">(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div style="text-align: center;">Brendan Brennan, CFO</div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland.</div>
    <div style="text-align: center;">Brendan.Brennan@iconplc.com</div>
    <div style="text-align: center;">00-353-1-291-2000</div>
    <div><br>
    </div>
    <div style="text-align: center;">&#160;(Name, telephone number, email and/or facsimile number and address of Company contact person)</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5f2e7b7af78b45d394dff2991868a23a" cellpadding="0" cellspacing="0">

        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Form 20-F &#9746;</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>Form 40-F &#9744;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes &#9744;</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No &#9746;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes &#9744;</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No &#9746;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes &#9744;</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No &#9746;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>If &#8220;Yes&#8221; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82 <font style="font-weight: bold;">N/A</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">As previously disclosed, on February 24, 2021, ICON plc, a public limited company in Ireland (&#8220;ICON&#8221;), ICON US Holdings Inc., a Delaware corporation and subsidiary of ICON (&#8220;US HoldCo&#8221;), and Indigo Merger Sub, Inc., a
      Delaware corporation and subsidiary of ICON and US HoldCo (&#8220;Merger Subsidiary&#8221;) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with PRA Health Sciences, Inc., a Delaware corporation (&#8220;PRA&#8221;). Upon the terms and subject to the
      conditions of the Merger Agreement, Merger Subsidiary will merge with and into PRA (the &#8220;Merger&#8221;), with PRA surviving as a subsidiary of ICON and US HoldCo.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The completion of the Merger is conditioned upon, among things, the early termination or expiration of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;HSR
      Act&#8221;), and the clearance of the Merger having been granted by the German Federal Cartel Office (Bundeskartellamt) (the &#8220;FCO&#8221;), in each case relating to the consummation of the Merger.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">On April 12, 2021, the FCO provided antitrust clearance for the Merger.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">On April 14, 2021, the applicable waiting period under the HSR Act with respect to the Merger expired.</div>
    <div><br>
    </div>
    <div>The completion of the Merger remains subject to other customary closing conditions, including the adoption of the Merger Agreement by PRA&#8217;s stockholders and the approval by ICON&#8217;s shareholders of the issuance of ICON ordinary shares in the Merger.
      ICON continues to expect the merger to close in the third quarter of 2021.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Cautionary Note Regarding Forward-Looking Statements</div>
    <div><br>
    </div>
    <div>This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
      amended. These forward-looking statements generally include statements regarding the potential transaction between ICON public limited company, a public limited company in Ireland (&#8220;ICON&#8221;) and PRA Health Sciences, Inc., a Delaware corporation
      (&#8220;PRA&#8221;), including any statements regarding the expected timetable for completing the potential transaction, the ability to complete the potential transaction, the expected benefits of the potential transaction (including anticipated synergies,
      projected financial information and future opportunities) and any other statements regarding ICON&#8217;s and PRA&#8217;s future expectations, beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance.
      These statements are often, but not always, made through the use of words or phrases such as &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar expressions. All such forward-looking
      statements are based on current expectations of ICON&#8217;s and PRA&#8217;s management and therefore involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the
      results expressed in the statements. Key factors that could cause actual results to differ materially from those projected in the forward-looking statements include the ability to obtain the requisite ICON and PRA stockholder approvals; uncertainties
      as to the timing to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that regulatory approvals are not obtained or are obtained subject to conditions that are not
      anticipated by the parties; potential litigation relating to the potential transaction that could be instituted against ICON, PRA or their respective directors; the effects of disruption to ICON&#8217;s or PRA&#8217;s respective businesses; restrictions during
      the pendency of the potential transaction that may impact ICON&#8217;s or PRA&#8217;s ability to pursue certain business opportunities or strategic transactions; the effect of this communication on ICON&#8217;s or PRA&#8217;s stock prices; transaction costs; ICON&#8217;s ability
      to achieve the benefits from the proposed transaction; ICON&#8217;s ability to effectively integrate acquired operations into its own operations; the ability of ICON or PRA to retain and hire key personnel; unknown liabilities; and the diversion of
      management time on transaction-related issues. Other important factors that could cause actual results to differ materially from those in the forward-looking statements include the effects of industry, market, economic, political or regulatory
      conditions outside of ICON&#8217;s or PRA&#8217;s control (including public health crises, such as pandemics and epidemics); risks regarding PRA&#8217;s ability to maintain large customer contracts or enter into new contracts; PRA&#8217;s ability to attract suitable
      investigators and patients for its clinical trials; PRA&#8217;s ability to keep pace with rapid technological change; PRA&#8217;s potential liability if a patient is harmed; and the factors set forth under the heading &#8220;Risk Factors&#8221; of ICON&#8217;s Annual Report on
      Form 20-F and PRA&#8217;s Annual Report on Form 10-K, and in subsequent filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). These risks, as well as other risks associated with the potential transaction, are more fully discussed in the
      joint proxy statement/prospectus filed with the SEC in connection with the proposed transaction. Other unpredictable or unknown factors not discussed in this communication could also have material adverse effects on forward-looking statements.
      Neither ICON nor PRA assumes any obligation to update any forward-looking statements, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div style="font-weight: bold;">No Offer or Solicitation</div>
    <div><br>
    </div>
    <div>This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer,
      solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the
      Securities Act of 1933, as amended.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Important Information for Investors and Stockholders</div>
    <div><br>
    </div>
    <div>In connection with the potential transaction, ICON has filed a registration statement on Form F-4 with the SEC containing a preliminary prospectus of ICON that also constitutes a preliminary proxy statement of each of ICON and PRA. The
      registration statement has not yet become effective. After the registration statement is declared effective, each of ICON and PRA will mail a definitive joint proxy statement/prospectus to stockholders of ICON and PRA, respectively. This
      communication is not a substitute for the joint proxy statement/prospectus or registration statement or for any other document that ICON or PRA have filed or may file with the SEC in connection with the potential transaction. INVESTORS AND SECURITY
      HOLDERS OF ICON AND PRA ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY
      BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the joint proxy statement/prospectus and other documents filed with the SEC by ICON or PRA through the website
      maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by ICON will be available free of charge on ICON&#8217;s website at https://www.iconplc.com and copies of the documents filed with the SEC by PRA will be available free
      of charge on PRA&#8217;s website at https://www.prahs.com/. Additionally, copies may be obtained by contacting the investor relations departments of ICON or PRA.</div>
    <div><br>
    </div>
    <div>ICON and PRA and certain of their respective directors, certain of their respective executive officers and other members of management and employees may be considered participants in the solicitation of proxies with respect to the potential
      transaction under the rules of the SEC. Information about the directors and executive officers of ICON is set forth in its annual report on Form 20-F, which was filed with the SEC on February 24, 2021. Information about the directors and executive
      officers of PRA is set forth in its Amendment to Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020, which was filed with the SEC on March 30, 2021. These documents can be obtained free of charge from the sources indicated
      above. Additional information regarding the interests of such participants in the solicitation of proxies in respect of the potential transaction are included in the registration statement and joint proxy statement/prospectus and other relevant
      materials filed with the SEC.</div>
    <div><br>
    </div>
    <div>The term &#8220;ICON&#8221; and such terms as &#8220;the company,&#8221; &#8220;our,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;its&#8221; may refer to ICON public limited company, one or more of its consolidated subsidiaries, or to all of them taken as a whole. All of these terms are used for convenience
      only and are not intended as a precise description of any of the separate companies, each of which manages its own affairs.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z22a7e4f9dd4f485f8ec58589aabc093f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 49%; vertical-align: middle;">&#160;</td>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 49%; vertical-align: middle;">
            <div style="font-weight: bold;">ICON plc</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: middle;">&#160;</td>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 49%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: middle;">&#160;</td>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 49%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: middle;">&#160;</td>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 49%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Brendan Brennan</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div>Date: April 16, 2021</div>
          </td>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 49%; vertical-align: middle;">
            <div>Brendan Brennan<br>
              Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
